Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures

BACKGROUND: Doxorubicin is considered one of the most potent established chemotherapeutics in the treatment of liposarcoma; however, the response rates usually below 30%, are still disappointing. This study was performed to identify gene expression changes in liposarcoma after doxorubicin treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Adrien, Daigeler, Ludger, Klein-Hitpass, Michael, Chromik Ansgar, Oliver, Müller, Jörg, Hauser, Heinz-Herbert, Homann, Hans-Ulrich, Steinau, Marcus, Lehnhardt
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585096/
https://www.ncbi.nlm.nih.gov/pubmed/18959781
http://dx.doi.org/10.1186/1471-2407-8-313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585096/
https://www.ncbi.nlm.nih.gov/pubmed/18959781
http://dx.doi.org/10.1186/1471-2407-8-313

Ejemplares similares